STAT3 down-regulates the expression of cyclin D during liver development

Area of Science:

• Molecular Biology
• Hepatology
• Cell Cycle Regulation

Background:

• Cyclin D1 is implicated in liver regeneration and tumor proliferation.
• The role of cyclin D1 in normal liver development is not well understood.
• D-type cyclins (D1, D2, D3) are key regulators of cell cycle progression.

Purpose of the Study:

• To investigate the role of cyclin D1 and other D-type cyclins in liver development.
• To elucidate the signaling pathways involved in regulating cyclin D expression during hepatocyte maturation.

Main Methods:

• Analysis of D-type cyclin expression during liver development.
• Primary culture of fetal hepatocytes treated with oncostatin M (OSM).
• Investigation of signaling pathways (STAT3, SHP-2/Ras) using receptor mutants and dominant-negative constructs.
• Studies in transgenic mice with STAT3-estrogen receptor fusion protein.
• Reporter assays using cyclin D1 promoter in fetal hepatocytes and liver tumor cells.

Main Results:

• D-type cyclin expression (D1, D2, D3) is down-regulated during liver development.
• Oncostatin M (OSM) down-regulates cyclin D1 and D2 expression in fetal hepatocytes, promoting differentiation.
• OSM-induced cyclin D down-regulation is mediated by STAT3 activation, not SHP-2/Ras.
• STAT3 activation is both necessary and sufficient for suppressing cyclin D1 and D2 in fetal hepatocytes.
• STAT3 activation suppresses cyclin D1 promoter activity in fetal hepatocytes but activates it in hepatic tumor cells.

Conclusions:

• STAT3 activation plays a critical role in down-regulating cyclin D1 and D2 expression during fetal liver development and maturation.
• The effect of STAT3 on cyclin D expression is context-dependent, suppressing it in differentiating fetal hepatocytes and activating it in tumor cells.
• This suggests STAT3-mediated regulation of cyclin D is specific to hepatocyte maturation and reduced proliferation potential.